D-serine Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

D-serine is an amino acid that is used in the biosynthesis of proteins. It was initially thought to exist in bacteria alone, however, was the second D amino acid discovered to naturally exist in humans.

D-serine is found in abundance in the brain and acts on the glycine binding site of the N-methyl-D-aspartate receptor (NMDAR) and modulates glutamate-mediated receptor activation.

It is found in high abundance in the brain and plays a major role in pathophysiology of schizophrenia. It is thus widely used for subsequent activation of NMDA receptors, to alleviate psychotic tendencies.

D-serine also plays a major role in synaptic plasticity and memory and is thus used in treatment of psychiatric and neurological conditions such as schizophrenia and glioma. Decreased levels of D-serine, seen in patients suffering from Schizophrenia, causes NMDAR hypofunction of the disorder. Thus the demand for D-serine as a novel therapeutic strategy is increasing, in turn, fueling growth of the D-serine market.

Increasing prevalence of psychotic disorders, in turn is expected to increase the demand for D-serine, thus boosting growth of the D-serine market. For instance, according to Mental Health America, 2017, 1 in 5 adults suffer from a mental health condition, accounting for over 40 million people in the U.S., with over half the population in New York and Florida combined.

Evonik Industries, a chemicals company, developed a new process for the enzymatic synthesis of the amino acid D-serine, L-serine, and DL-serine. The production capacities at the Nanning site of the company located in China thus increased. The company is adopting full backward integration strategies, to offer customers the highest level of supply security and product quality.
Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/187531
Lifespan Biosciences Inc., an immunohistochemistry antibody company, announced an initiative to release 20,000 immunohistochemistry-validated reagent antibodies over the next four years.

Sigma-Aldrich Corporation is an American chemical, life science and biotechnology company, engaged in the production and supply of D-serine, to the healthcare sector.
Get Best Discount on Research Report: https://www.worldwidemarketreports.com/discount/187531
Interchim, a privately owned French company specialized in manufacturing and distribution of reagents, consumables and dedicated instruments for the R&D and industry laboratory in the fields of fine chemistry, chromatography and bio-analysis, also focuses on the development of D-serine.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

1001 4th Ave,
#3200
Seattle, WA 98154,
U.S

This release was published on openPR.